Pharmaceutical buffer salts that can be utilized for buffering and modulating the pH of the formulation.
|
Product |
Features |
Regulatory Status |
|
PharSQ®Base MP 30 |
Monopotassium phosphate; KH2PO4 Mean particle size of 250µm |
USP-NF/EP |
|
PharSQ®Base DP 20 |
Dipotassium phosphate; K2HPO4 Mean particle size of 150µm |
EP |
|
PharSQ®Base TP 30 |
Tripotassium phosphate; K3PO4 Mean particle size of 160µm |
- |
|
PharSQ®Base MS 20 |
Monosodium phosphate anhydrous; NaH2PO4 Mean particle size of 150µm |
USP |
|
PharSQ®Base MS 41 |
Monosodium phosphate monohydrate; NaH2PO4.H2O Mean particle size of 650µm |
USP |
|
PharSQ®Base MS 42 |
Monosodium phosphate dihydrate; NaH2PO4.2 H2O Mean particle size of 680µm |
USP/EP |
|
PharSQ®Base DS 30 |
Disodium phosphate anhydrous; Na2HPO4 Mean particle size of 280µm |
USP/EP |
|
PharSQ®Base DS 42 |
Disodium phosphate dihydrate; Na2HPO4.2H2O Mean particle size of 850µm |
USP/EP |
|
PharSQ®Base DS 47 |
Disodium phosphate heptahydrate; Na2HPO4.7H2O Mean particle size of 850µm |
USP |
|
PharSQ®Base DS 49 |
Disodium phosphate dodecahydrate; Na2HPO4.12 H2O Mean particle size of 600µm |
USP/EP |
|
PharSQ®Base TS 20 |
Trisodium phosphate anhydrous; Na3PO4 Mean particle size of 125µm |
USP-NF |
|
PharSQ®Base TS 59 |
Trisodium phosphate dodecahydrate; Na3PO4.12 H2O Mean particle size of 600µm |
USP-NF |